Home » How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

August 5, 2026August 5, 2026
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

This post was originally published on this site.

The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.
bitcoin
Bitcoin (BTC) $ 64,626.00
ethereum
Ethereum (ETH) $ 1,906.33
tether
Tether (USDT) $ 0.999168
xrp
XRP (XRP) $ 1.06
bnb
BNB (BNB) $ 595.17
dogecoin
Dogecoin (DOGE) $ 0.070014
solana
Solana (SOL) $ 74.07
usd-coin
USDC (USDC) $ 0.99959
staked-ether
Lido Staked Ether (STETH) $ 2,265.05
avalanche-2
Avalanche (AVAX) $ 6.64
tron
TRON (TRX) $ 0.327693
wrapped-steth
Wrapped stETH (WSTETH) $ 2,779.67
sui
Sui (SUI) $ 0.689417
chainlink
Chainlink (LINK) $ 8.15
weth
WETH (WETH) $ 2,268.37
polkadot
Polkadot (DOT) $ 0.839852